Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...
20 May, 2026, 12.06 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
24 Apr, 2026, 09.03 AM IST
Iran war halts but missiles would echo in Q4 results: 40 stocks may report over 20% profit dipIndia's corporate earnings for the quarter ended March 2026 are feeling the economic heat from the recent Israel-US-Iran conflict. While so...
09 Apr, 2026, 11.37 AM IST
Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
02 Apr, 2026, 12.13 PM IST
Cipla shares rally 6% in 2 days as Q1 results impress; brokerages raise target up to Rs 1,875Cipla shares: Following the earnings announcement, several brokerage firms revised their target price for the stock, with some estimates re...
28 Jul, 2025, 11.57 AM IST
Cipla expects record 24 per cent Ebitda margin in FY24"We enter reverse seasonalist in our India business. The fourth quarter has always been the lowest, so that impacts our margins," Umang Voh...
26 Jan, 2024, 12.30 AM IST
Cipla shares jump 7%, hit 52-week high on strong Q3 earningsOn Monday, Cipla reported a 31.8% year-on-year (YoY) jump in its October-December quarter consolidated net profit at Rs 1,056 crore. It was...
23 Jan, 2024, 10.21 AM IST
Cipla Q2 Results: Profit jumps 43% YoY to Rs 1,131 crore, revenue rises 15%The bottomline was higher than the Rs 1,006 crore which was expected by analysts in an ET Now poll. Cipla's consolidated margin came in at ...
27 Oct, 2023, 02.43 PM IST
Analysts expect Cipla to return up to 30% from here on as India biz gains momentumKotak Securities said the expansion of the Covid portfolio would support near-term earnings while the continued rollout of respiratory fran...
18 May, 2021, 07.23 AM IST
Q4 earning preview: Pharma pack up for good show, may go unscathed from virus hitInvestors may keenly follow Sun Pharma earnings for updates on Halol OAI.
16 Apr, 2020, 04.01 PM IST
Buy Cipla, target price Rs 523: Nirmal BangTthe brokerage has downward revised its FY21 and FY22 forecasts on Cipla, having knocked off Voltaren sales number and pushed Albuterol inh...
31 Mar, 2020, 12.44 PM IST
Analysts downgrade Cipla as company hints at headwindsIn its quarterly investor presentation, Cipla listed some emerging challenges for the next two quarters.
07 Nov, 2018, 08.14 AM IST
Buy Cipla, target Rs 720: SharekhanBuy Cipla Ltd. at a price target of Rs 720.
09 Aug, 2018, 03.23 PM IST
- Hold Cipla Ltd. target Rs 585 : Sharekhan
Hold Cipla Ltd. at a price target of Rs 585. The Cipla management has guided for a double-digit growth in the US and India businesses.
26 May, 2017, 08.58 AM IST
Cipla posts 44% rise in Q2 net profit; India sales flatIn the past quarter, Cipla posted Rs 3,452 crore of revenue, compared with Rs 2,767 crore a year earlier.
06 Nov, 2015, 01.44 AM IST
Nomura neutral on Cipla, target Rs 689Cipla has acquired a portfolio of largely plain vanilla oral solids where its capabilities are already well-established, and hence the acqu...
07 Sep, 2015, 09.28 AM IST